Pulsed Field Ablation Innovator, Arga, has just raised €54 million in an oversubscribed financing round. The investors included Advent Life Sciences (UK), Earlybird Health (Germany), a new investor Gilde Healthcare (the Netherlands) as well as an undisclosed strategic investor. This start-up was founded by David Naele and Randy Werneth in 2020, to develop Coherent Sine-Burst Electroporation™ (CSE™), a next-generation cardiac ablation system for treating cardiac arrhythmias, including atrial fibrillation. Supporting Argá Medtech SA since its formation, Kellerhals Carrard advised on the Swiss contractual aspects of this round and collaborated with Wilson Sonsini Goodrich & Rosati from the US side. The Kellerhals Carrard team was led by Jean-Luc Chenaux (pictured) (Partner, M&A), and further comprised Frédéric Rochat (Partner, M&A), François Kaiser (Partner, M&A), Serge Migy (Partner, Tax) Virginie A. Rodieux (Partner, IP) as well as Cindy Liu-Ung and Joséphine Marmy (Senior Associates, M&A) and Brian Jurt (Tax advisor). Read the article >> https://lnkd.in/dJe2u5Qu #Legalcommunitych #legaladvisor #financinground
Legalcommunity.ch’s Post
More Relevant Posts
-
🌟 Exciting news! After 15 months working with ILC Therapeutics as their fractional CFO, I’m thrilled to share that our recent fundraising round has been a success, and the cherry on top, my journey with the company continues 🚀. This round is a major milestone, helping us advance our two lead assets Alfacyte™ & Dermacyte™ towards clinic and hit key value inflection points for the business. 🎯 For those not in biotech, the closing of a fundraising round isn’t the time to slow down—it’s time to accelerate! 💥 and that's exactly what we are doing! I do have a sliver of capacity left (1-4 days/month) for fractional CFO work. If you or someone you know needs support, drop me a message! 📩 #FractionalCFO #FundraisingSuccess #Biotech #ClinicalTrials #Startups #CFO #BusinessGrowth #BiotechStartups #Leadership #Finance #Fundraising
Today we announced the completion of a £2.5m fundraise led by Eos, Scottish Enterprise, Medical Incubator Japan K.K. and Robert Kopple, that will support the continued pre-clinical development of our two lead assets, Alfacyte™ and Dermacyte™ as they move towards the clinic. Along with the funding we were delighted to announce the appointments of Owain Millington as Chief Executive Officer, Julie Bailey as Chief Financial Officer, and Dawn Firmin as Chief Operations Officer. https://lnkd.in/eaS_-_z2 #innovation #hybridinterferons
-
-
💰 Moximed secures $91m financing to commercialise its MISHA knee system The new investors, including Cormorant Asset Management and Warren Point Capital, have participated in the financing round, along with existing investors. The existing investors include New Enterprise Associates (NEA), Future Fund, Advent Life Sciences, Gilde Healthcare, Vertex Ventures HC, GBS Venture Partners, and Morgenthaler Ventures. Moximed intends to use the proceeds from the financing round to advance the commercialisation of its MISHA Knee System in the US. Read more online: https://lnkd.in/efXVBGq2 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
-
-
Discover more Baby HMO investment deals on our latest Deal Clinic with Sheena Almas! 🚀📈 Full analysis and tips on Youtube >> https://lnkd.in/gfUUgAS2 #SourcingInvestments #PropertySourcing #ProperyClinic #InvestmentProperty #HMO #babyhmo
-
The benefits of Baby HMO investments: 'juicy' cash flow and capital growth. 💷📈 Learn how to create a winning investment strategy by watching our full discussion on our latest Deal Clinic >> https://lnkd.in/g4g7NW7q #SourcingInvestments #PropertySourcing #ProperyClinic #InvestmentProperty #HMO #babyhmo
-
At these complex times, each success is amazing. Recently, it was inspiring to see not one, but several prominent achievements coming from the Israeli #healttech eco-system. Daria Lemann-Blumenthal, led BELKIN Vision to one of the most prominent strategic acquisitions in the Israeli #medtech. Keren Leshem, completed a successful $10mil fundraising for OCON Therapeutics , a remarkable milestone in the #womenhealth domain. These achievements are a testament to our resilience and proof that with the right approach, there is a way to create success against all odds! I invited Keren and Daria to join us for a MedTech Marketing at Scale #HealthTech #ExecutivePanel to speak about their recent journey and share insights, tips, and recommendations with our community. The panel will be joined by Dr. Avital Adler, PhD, Principal at aMoon Fund. Avital brings a broad perspective on the global private and public health-tech markets. She will speak about the market outline for #biotech , #digitalhealth, and #medicaldevices and discuss what turns the company into a success both in fundraising and IPO processes. I couldn't be more excited to put together and moderate such an inspiring panel. I invite you to join us and grab this unique chance to gain first-hand insights from these remarkable #womenleaders! Sign-up here: https://lnkd.in/d7_dnq4h #fundraising #strategic #acquisition #businesssuccess #knowledgesharing #partnership #marketingexpert #CMO
-
-
The benefits of Baby HMO investments: 'juicy' cash flow and capital growth. 💷📈 Learn how to create a winning investment strategy by watching our full discussion on our latest Deal Clinic >> https://lnkd.in/gfUUgAS2 #SourcingInvestments #PropertySourcing #ProperyClinic #InvestmentProperty #HMO #babyhmo
-
Braveheart Investment Group PLC (AIM:BRH) has confirmed it has written down the values of its two main holdings - instrument company Paraytec and Kirkstall, which has developed technology to replace animals in medical testing. "The board believes that, with time, both Kirkstall and Paraytec could have the potential to increase in value and provide exit opportunities for the company, but it is prudent to write the values down to zero at the current time," the company said in commentary accompanying its prelims. As a result of these adjustments, the company posted a pre-tax loss for the 12 months ending March 31 of £8.19 million. It exited the year with £1.74 million of cash and owns investments worth £1.65 million. Investors were told Braveheart had implemented a "range of actions to rationalise the company's cost base and to conserve cash". More at #Proactive #ProactiveInvestors http://ow.ly/1n4r105xCgm
Braveheart makes tough call on key investments
proactiveinvestors.co.uk
-
WISE SpA, a leader in advanced implantable electrodes for neuromonitoring and neuromodulation, has closed a €25 million financing round. 💰 This includes equity investment and a venture debt loan from the European Investment Bank (EIB), supported by InvestEU. The funds will advance the Heron® lead for spinal cord stimulation and commercialize the WISE Cortical Strip (WCS®) for neuromonitoring. Key points: 🧠New investor: Wallaby SpA (Scagliarini family, GVS SpA) joins existing partners. 🧠Transitioned to a Joint Stock Company (S.p.A.). 🧠Focus on Heron® lead development and WCS® commercialization. CEO Luca Ravagnan said: “The contextual EIB decision to enter into a financing agreement with WISE, following thorough due diligence of the company’s business, further demonstrates the growing confidence in our innovative technology to revolutionize the spinal cord stimulation market.” Full article in the comments. #WISE #Neurotech #Neuromodulation #Investment #EIB #neuromonitoring
-
-
US-based global investment giant KKR has signed the definitive agreements for acquiring Healthium Medtech Ltd, a leading Indian medical devices company, from an affiliate of funds advised by Apax Partners LLP, a leading global private equity advisory firm. While the firm didn't disclose the financial terms of the deal, an ET report said KKR has valued the Indian company at Rs 7,000 crore, inclusive of debt. Healthium Medtech develops, manufactures and sells surgical products globally. Apax Funds acquired Healthium in 2018. Read the full story here: 👇 https://lnkd.in/d5BPA-mC #investment #healthcare #acquisition #Investors #company #indianstartupnews
-
-
Moximed closed a Series D preferred stock financing worth up to $91 million. The funding round includes $61 million and an option to close on up to an additional $30 million. 👏 ⭐ Elevage Medical Technologies, a Patient Square Capital platform, led the round. New investors Cormorant Asset Management, LP and Warren Point Capital joined in the funding. Existing investors New Enterprise Associates (NEA), Future Fund, Advent Life Sciences, Gilde Healthcare, Vertex Ventures HC, GBS Venture Partners and MORGENTHALER VENTURE PARTNERS IX LP all participated. 💬 “This financing is validation of the significant market opportunity for the MISHA Knee System,” said Christopher Gleason, President and CEO of Moximed. 🔗 Learn more: https://lnkd.in/djdDtwkt #MedicalDevice #MedTech #MedicalEquipment #HealthTech #Knee #Orthopaedics #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
-
